Incessant threat of COVID-19 variants: Highlighting need for a mix of FDA-approved artificial intelligence tools and community pharmacy services

Seamless integration of artificial intelligence (AI) technology, especially FDA-approved AI tools, in community pharmacies can build increasingly effective and easy care pathways, thereby minimizing burden on healthcare system, and ensuring compliance to preventive measure through limiting hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadeem, Muhammad Faisal, Matti, Nazish, Parveen, Shagufta, Rafiq, Sehrish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294695/
https://www.ncbi.nlm.nih.gov/pubmed/34391673
http://dx.doi.org/10.1016/j.sapharm.2021.07.018
_version_ 1783725282577874944
author Nadeem, Muhammad Faisal
Matti, Nazish
Parveen, Shagufta
Rafiq, Sehrish
author_facet Nadeem, Muhammad Faisal
Matti, Nazish
Parveen, Shagufta
Rafiq, Sehrish
author_sort Nadeem, Muhammad Faisal
collection PubMed
description Seamless integration of artificial intelligence (AI) technology, especially FDA-approved AI tools, in community pharmacies can build increasingly effective and easy care pathways, thereby minimizing burden on healthcare system, and ensuring compliance to preventive measure through limiting hospital visits. In this regard, the WHO needs to enlist and provide guidance on most promising AI tools that can be implemented in community pharmacy settings.
format Online
Article
Text
id pubmed-8294695
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-82946952021-07-22 Incessant threat of COVID-19 variants: Highlighting need for a mix of FDA-approved artificial intelligence tools and community pharmacy services Nadeem, Muhammad Faisal Matti, Nazish Parveen, Shagufta Rafiq, Sehrish Res Social Adm Pharm Article Seamless integration of artificial intelligence (AI) technology, especially FDA-approved AI tools, in community pharmacies can build increasingly effective and easy care pathways, thereby minimizing burden on healthcare system, and ensuring compliance to preventive measure through limiting hospital visits. In this regard, the WHO needs to enlist and provide guidance on most promising AI tools that can be implemented in community pharmacy settings. Elsevier Inc. 2022-06 2021-07-21 /pmc/articles/PMC8294695/ /pubmed/34391673 http://dx.doi.org/10.1016/j.sapharm.2021.07.018 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Nadeem, Muhammad Faisal
Matti, Nazish
Parveen, Shagufta
Rafiq, Sehrish
Incessant threat of COVID-19 variants: Highlighting need for a mix of FDA-approved artificial intelligence tools and community pharmacy services
title Incessant threat of COVID-19 variants: Highlighting need for a mix of FDA-approved artificial intelligence tools and community pharmacy services
title_full Incessant threat of COVID-19 variants: Highlighting need for a mix of FDA-approved artificial intelligence tools and community pharmacy services
title_fullStr Incessant threat of COVID-19 variants: Highlighting need for a mix of FDA-approved artificial intelligence tools and community pharmacy services
title_full_unstemmed Incessant threat of COVID-19 variants: Highlighting need for a mix of FDA-approved artificial intelligence tools and community pharmacy services
title_short Incessant threat of COVID-19 variants: Highlighting need for a mix of FDA-approved artificial intelligence tools and community pharmacy services
title_sort incessant threat of covid-19 variants: highlighting need for a mix of fda-approved artificial intelligence tools and community pharmacy services
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294695/
https://www.ncbi.nlm.nih.gov/pubmed/34391673
http://dx.doi.org/10.1016/j.sapharm.2021.07.018
work_keys_str_mv AT nadeemmuhammadfaisal incessantthreatofcovid19variantshighlightingneedforamixoffdaapprovedartificialintelligencetoolsandcommunitypharmacyservices
AT mattinazish incessantthreatofcovid19variantshighlightingneedforamixoffdaapprovedartificialintelligencetoolsandcommunitypharmacyservices
AT parveenshagufta incessantthreatofcovid19variantshighlightingneedforamixoffdaapprovedartificialintelligencetoolsandcommunitypharmacyservices
AT rafiqsehrish incessantthreatofcovid19variantshighlightingneedforamixoffdaapprovedartificialintelligencetoolsandcommunitypharmacyservices

Ejemplares similares